t
Marechale Capital plc granted a total of 8,750,000 options over its ordinary shares on 10 July 2026, with an exercise price of 4.75 pence per share. These options were issued to Directors, a PDMR, and an employee. Following this grant, the company has 24,016,076 options in issue, representing approximately 9.33% of its 257,287,255 ordinary shares.
| Date | 13 Jul 2026 |
| Time | 09:30:00 |
| Category | Director/PDMR Shareholding |
| ID | 202607130056 |
Disseminated via PRN on 13 July 2026
13 July 2026
Marechale Capital plc
(“Marechale” or the "Company")
Grant of Options
Director/PDMR Dealing
Marechale Capital plc (AIM: MAC), an established City of London based corporate finance advisory business, developing into a fully integrated digital merchant bank providing corporate finance, capital markets and asset management services underpinned by a technology solutions and distribution platform, announces that it has granted in aggregate 8,750,000 options over ordinary shares of the Company, at an exercise price of 4.75 pence per ordinary share, being the closing mid-market price on 10 July 2026 (the “Share Options") to Directors, a PDMR and an employee of the Company.
Further details of the grant of Share Options are set out in the Notification of Dealing Form below.
| Number of Share Options Granted | Resultant Number of Share Options Held | As a % of Current Issued Share Capital | |
| Mark Warde-Norbury | 3,000,000 | 4,315,217 | 1.68% |
| Patrick Booth-Clibborn | 3,000,000 | 13,900,859 | 5.40% |
| Patrick Claridge | 1,500,000 | 1,500,000 | 0.58% |
| Nick Cowan | 750,000 | 750,000 | 0.29% |
| Others | 500,000 | 1,450,000 | 0.56% |
| Total | 8,750,000 | 21,916,076 | 8.52% |
The issued share capital of the Company is 257,287,255 ordinary shares. Following the grant of the Share Options, the Company will have 24,016,076 options over ordinary shares in issue representing approximately 9.33 per cent. of the Company’s current issued share capital.
Related Party Transactions
The grant of options to Mark Warde-Norbury, Patrick Booth-Clibborn and Patrick Claridge constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies by virtue of them being Directors of the Company (the “Transaction”). With the exception of Mark Warde-Norbury, Patrick Booth-Clibborn and Patrick Claridge, the Director independent of the Transaction, being Chris Kenning, having consulted with the Company’s nominated adviser, Cairn Financial Advisers LLP, considers that the terms of the Transaction are fair and reasonable insofar as shareholders are concerned.
This announcement contains inside information for the purposes the UK Market Abuse Regulation.
For further information please contact:
Enquiries
|
Marechale Capital Patrick Booth-Clibborn / Mark Warde-Norbury |
Tel: +44 (0)20 7628 5582 |
|
Cairn Financial Advisers LLP (Nominated Adviser) Jo Turner / Sandy Jamieson |
Tel: +44 (0)20 7213 0880 |
|
Vigo Consulting (Financial Public Relations) Jeremy Garcia / Joe Quinlan |
Tel: +44 (0)20 7390 0230 |
About Marechale Capital plc
Marechale Capital plc is one of the UK's first publicly quoted, fully integrated digital merchant banks.
The Group bridges traditional and digital asset markets, sitting at the centre of a rapidly growing market for tokenised assets. The Group operates across four businesses - Marechale Capital, Stanford Capital Partners, Blubird Global, Inc, and NJC Capital Management Limited- providing services across corporate finance, capital markets, tokenisation and asset management. This comprehensive offering is underpinned by ownership of the Blubird technology platform.
Marechale Capital plc is quoted on the AIM Market of the London Stock Exchange under the ticker MAC.
For more information: https://marechalecapital.com/
Forward looking statement disclaimer
Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.
The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.
| Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | |||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a. | Name |
|
|||
| 2 | Reason for notification | ||||
| a. | Position/Status |
|
|||
| b. | Initial notification/ Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a. | Name | Marechale Capital plc | |||
| b. | LEI | 2138003NUK6SXCDIAT89 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a. |
Description of the financial instrument, type of instrument Identification Code |
Grant of Options over Ordinary Shares
ISIN: GB0005401087 |
|||
| b. | Nature of the transaction | Grant of options over ordinary shares | |||
| c) | Price(s) and volume(s): | Price(s) per share (p) | Volume(s) | ||
|
|
||||
| d. |
Aggregated information
|
8,250,000 4.75p |
|||
| e. | Date of the transaction | 10/07/2026 | |||
| f. | Place of the transaction | Outside a trading venue | |||
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
